Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 7.43 USD -1.2% Market Closed
Market Cap: 515.4m USD

Wall Street
Price Targets

BCYC Price Targets Summary
Bicycle Therapeutics PLC

Wall Street analysts forecast BCYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCYC is 22.01 USD with a low forecast of 6.06 USD and a high forecast of 46.2 USD.

Lowest
Price Target
6.06 USD
18% Downside
Average
Price Target
22.01 USD
196% Upside
Highest
Price Target
46.2 USD
522% Upside
Bicycle Therapeutics PLC Competitors:
Price Targets
CUV
Clinuvel Pharmaceuticals Ltd
113% Upside
FHTX
Foghorn Therapeutics Inc.
167% Upside
AZT
Arcticzymes Technologies ASA
59% Upside
002007
Hualan Biological Engineering Inc
27% Upside
MSB
Mesoblast Ltd
28% Upside
2142
Hbm Holdings Ltd
2% Upside
KURA
Kura Oncology Inc
222% Upside
AGIO
Agios Pharmaceuticals Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Bicycle Therapeutics PLC

For the last 7 years the compound annual growth rate for Bicycle Therapeutics PLC's revenue is 50%. The projected CAGR for the next 3 years is 13%.

50%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bicycle Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Bicycle Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCYC's stock price target?
Price Target
22.01 USD

According to Wall Street analysts, the average 1-year price target for BCYC is 22.01 USD with a low forecast of 6.06 USD and a high forecast of 46.2 USD.

What is Bicycle Therapeutics PLC's Revenue forecast?
Projected CAGR
13%

For the last 7 years the compound annual growth rate for Bicycle Therapeutics PLC's revenue is 50%. The projected CAGR for the next 3 years is 13%.

Back to Top